Emagene.Life and Adam Health Partner to Advance Precision Longevity and Functional Medicine

25 May 2026

KUALA LUMPUR: Men’s health is entering a new era of measurable, AI-informed precision care as Emagene.life announces a strategic partnership with Adam Health to promote functional medicine, longevity optimisation, and biodata-driven male health insights. Emagene.life will be distributing the Adam Health sensor in Malaysia and Singapore.

Emagene.life and Adam Health unveil a strategic alliance to advance AI-powered precision men’s health, longevity enhancement, and biodata-driven wellness across Malaysia and Singapore.

This collaboration combines Emagene.life’s expertise in functional medicine and its AI-integrated health intelligence ecosystem with Adam Health’s innovative men’s wellness platform, delivering a more personalised, measurable approach to male vitality, performance, recovery, and long-term health outcomes.

Despite medical advances, many men continue to silently struggle with declining energy, hormonal imbalance, reduced libido, chronic stress, metabolic dysfunction, and accelerated ageing — often without early detection tools or personalised health insights.

At the core of this partnership is a shared mission: enabling men to understand what their bodies are communicating in real time. Traditional healthcare models tend to focus on symptoms only after decline has occurred. This initiative offers earlier insights, more precise interventions, and measurable pathways towards improved energy, libido, hormonal resilience, metabolic health, recovery, and long-term vitality.

An integrated ecosystem is being introduced that combines functional medicine assessments and personalised longevity strategies with advanced biodata measurement and physiological tracking. Data from the Adam Sensor, combined with AndroAge™ scoring, provides measurable insights into men's health. AI-assisted interpretation, powered by Avio Health technology, further enhances understanding by translating complex physiological signals into actionable intelligence. The approach is centred on personalised wellness protocols tailored to individual biomarkers and lifestyle patterns.

The Adam Sensor is the world’s first consumer device designed for at-home measurement of nocturnal erections, which are a key early biomarker of male cardiovascular, hormonal, and metabolic health. Nocturnal erection patterns can reveal underlying dysfunction years before symptoms manifest, making them a powerful tool for proactive men’s health. Sensor data feeds into AndroAge™, Adam Health’s proprietary wellness score that consolidates complex physiological signals into a single, trackable measure of male vitality.

By integrating Avio Health’s AI technology, Emagene.life aims to transform complex health data into actionable insights. Instead of relying solely on generic wellness advice, patients gain a deeper understanding of the biological patterns that influence their performance, cardiovascular health, stress response, sleep quality, recovery, hormonal balance, and sexual wellness.

The demand for personalised men’s health solutions continues to grow globally, driven by increasing interest in longevity science, hormone optimisation, preventative health strategies, wearable biodata tracking, and AI-supported wellness technologies.

A spokesperson from Emagene.life explained, “The future of healthcare is shifting from reactive treatment to measurable optimisation. Men are no longer just looking for symptom management — they want real insights into their performance, recovery, hormones, metabolism, sleep, and longevity. When biodata, functional medicine, and AI are integrated, entirely new possibilities for personalised health emerge.”

Representatives from Adam Health also highlighted that this collaboration reflects the rising demand for modern, proactive men’s healthcare solutions.

“Today’s men seek clarity, personalised plans, measurable progress, and sustainable performance. This partnership aims to expand access to a more data-informed, longevity-focused model of men’s health.”

Looking ahead, both companies anticipate expanding their joint efforts into digital health initiatives, biomarker intelligence, customised wellness programmes, and AI-supported preventative care frameworks in the coming months.

This initiative exemplifies a broader shift towards precision health, where technology, functional medicine, and real-time biological feedback converge to support healthier ageing and an improved quality of life for men worldwide.